Compounds > rc 3095
Page last updated: 2024-09-03

rc 3095 and Adenocarcinoma

rc 3095 has been researched along with Adenocarcinoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, RZ; Ertl, T; Groot, K; Horvàth, JE; Qin, Y; Schally, AV1
Ertl, T; Halmos, G; Pinski, J; Qin, Y; Schally, AV; Szepeshazi, K; Yano, T1
Groot, K; Halmos, G; Miller, G; Milovanovic, S; Radulovic, S; Reile, H; Schally, AV; Szepeshazi, K; Yano, T1
Halmos, G; Pinski, J; Schally, AV; Szepeshazi, K1
Cai, RZ; Milovanovic, S; Radulovic, S; Schally, AV; Szepeshazi, K; Szoke, B1

Other Studies

5 other study(ies) available for rc 3095 and Adenocarcinoma

ArticleYear
Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP.
    International journal of cancer, 1995, Oct-09, Volume: 63, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bombesin; Cell Division; Cyclic AMP; Gastrin-Releasing Peptide; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Peptide Fragments; Peptides; Tumor Cells, Cultured

1995
Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.
    International journal of cancer, 1994, May-15, Volume: 57, Issue:4

    Topics: Adenocarcinoma; Amino Acid Sequence; Animals; Antineoplastic Agents; Binding Sites; Body Weight; Bombesin; Cell Division; Epidermal Growth Factor; Female; Humans; Insulin-Like Growth Factor I; Male; Mice; Mice, Nude; Middle Aged; Molecular Sequence Data; Neoplasm Transplantation; Octreotide; Peptide Fragments; Somatostatin; Stomach Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured

1994
Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice.
    Acta oncologica (Stockholm, Sweden), 1994, Volume: 33, Issue:6

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bombesin; Colonic Neoplasms; Drug Screening Assays, Antitumor; ErbB Receptors; Gastrin-Releasing Peptide; Gastrins; Growth Hormone; Humans; Insulin-Like Growth Factor I; Liver Neoplasms; Male; Mice; Mice, Nude; Neoplasm Transplantation; Peptide Fragments; Peptides; Radioligand Assay; Somatostatin

1994
Antagonists of bombesin/gastrin-releasing peptides as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Cancer, 1993, Dec-01, Volume: 72, Issue:11

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bombesin; Connective Tissue; ErbB Receptors; Gastrin-Releasing Peptide; Gonadotropin-Releasing Hormone; Male; Mitosis; Peptide Fragments; Peptides; Prostatic Neoplasms; Rats; Rats, Inbred F344; Rats, Inbred Strains; Receptor, IGF Type 1; Receptors, Bombesin; Testosterone; Time Factors

1993
Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
    Cancer research, 1991, Nov-01, Volume: 51, Issue:21

    Topics: Adenocarcinoma; Amino Acid Sequence; Animals; Antineoplastic Agents; Bombesin; Carcinogens; Cell Membrane; Cricetinae; ErbB Receptors; Female; Gastrins; Mesocricetus; Molecular Sequence Data; Nitrosamines; Organ Size; Pancreatic Neoplasms; Peptide Fragments; Receptors, Bombesin; Receptors, Neurotransmitter; Somatostatin

1991